Status:
COMPLETED
Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Palliative care is defined as multidisciplinary care that increases quality of life (QOL) for patients with a life-threatening illness. Although it is known that patients with the most severe physical...
Detailed Description
Randomized controlled trials (RCTs) have shown when patients with advanced cancer were referred early to specialized palliative care teams, they had improved QOL, symptom control, and greater satisfac...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of stage IV cancer (advanced); hormone-refractory for breast or prostate cancer; stage III or IV for lung cancer and pancreatic cancer; patients with stage III cancer and poor clinical prognosis, e.g. ovarian or esophageal cancer, will be included at the discretion of the oncologist
- ECOG performance status ≤ 2 (estimated by primary oncologist)
- Prognosis of \>6 months (estimated by primary oncologist)
- Patient completes symptom screening in outpatient clinic electronically
Exclusion
- Insufficient English literacy to complete questionnaires
- Inability of pass the cognitive screening test (SOMC - Short Orientation Memory Concentration test score \<20 or \>10 errors)
- Receiving specialized palliative care within the last 6 months prior to screening, per chart and patient statement.
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04044040
Start Date
September 1 2016
End Date
July 1 2018
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2C1